Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: A systematic review of the literature

Respiratory Medicine

Volumn 104, Issue 7, 2010, Pages 934-944

  Molassiotis, A ^a   Bryan, G ^a   Caress, A ^a   Bailey, C ^b   Smith, J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Asthma; Bronchitis; COPD; Cough; Respiratory disease; Systematic review

Indexed keywords

ACETYLCYSTEINE; ANESTHETIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BECLOMETASONE; BRONCHODILATING AGENT; BUDESONIDE; CHLOROFLUOROCARBON; CODEINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESOMEPRAZOLE; GLYCEROL; HERBACEOUS AGENT; IPRATROPIUM BROMIDE; LANSOPRAZOLE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIDOCAINE; LODOXAMIDE; MORPHINE; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEDOCROMIL SODIUM; OMEPRAZOLE; OPIATE DERIVATIVE; OXITROPIUM BROMIDE; PLACEBO; SALBUTAMOL; STEROID; THEOPHYLLINE; UNINDEXED DRUG;

ALTERNATIVE MEDICINE; ASTHMA; BEHAVIOR THEORY; BITTER TASTE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COUGHING; DRUG EFFICACY; EVIDENCE BASED MEDICINE; GASTROESOPHAGEAL REFLUX; HEART PALPITATION; HUMAN; LOW DRUG DOSE; MEDICAL INFORMATION SYSTEM; PARESTHESIA; PATIENT EDUCATION; PATIENT MONITORING; PHYSIOTHERAPY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SELF CARE; SIDE EFFECT; SINGLE DRUG DOSE; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT RESPONSE; TREMOR;

ADRENAL CORTEX HORMONES; ADULT; ANTITUSSIVE AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHRONIC DISEASE; COUGH; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77952882103     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.02.010     Document Type: Review

References (94)

1. Davis C.L. ABC of palliative care. Breathlessness, cough, and other respiratory problems. British Medical Journal 315 7113 (1997 Oct 11) 931-934
2. Irwin R.S., and Madison J.M. The diagnosis and treatment of cough. The New England Journal of Medicine 343 23 (2000 Dec 7) 1715-1721
3. Pratter M.R., Brightling C.E., Boulet L.P., and Irwin R.S. An empiric integrative approach to the management of cough: aCCP evidence-based clinical practice guidelines. Chest 129 Suppl. 1 (2006 Jan) 222S-231S
4. Dicpinigaitis P.V., Tso R., and Banauch G. Prevalence of depressive symptoms among patients with chronic cough. Chest 130 6 (2006 Dec) 1839-1843
5. McGarvey L.P., Carton C., Gamble L.A., Heaney L.G., Shepherd R., Ennis M., et al. Prevalence of psychomorbidity among patients with chronic cough. Cough 2 (2006) 4
6. Watson M.S. Oxford handbook of palliative care (2005), Oxford University Press, Oxford; New York
7. Irwin R.S. Complications of cough: aCCP evidence-based clinical practice guidelines. Chest 129 Suppl. 1 (2006 Jan) 54S-58S
8. Irwin R.S., Baumann M.H., Bolser D.C., Boulet L.P., Braman S.S., Brightling C.E., et al. Diagnosis and management of cough executive summary: aCCP evidence-based clinical practice guidelines. Chest 129 Suppl. 1 (2006 Jan) 1S-23S
9. Madison J.M., and Irwin R.S. Pharmacotherapy of chronic cough in adults. Expert Opinion on Pharmacotherapy 4 7 (2003 Jul) 1039-1048
10. Irwin R.S., and Madison J.M. The persistently troublesome cough. American Journal of Respiratory and Critical Care Medicine 165 11 (2002 Jun 1) 1469-1474
11. Robinson K.A., and Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International Journal of Epidemiology 31 1 (2002 Feb) 150-153
12. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 17 1 (1996 Feb) 1-12
13. Ciprandi G., Buscaglia S., Catrullo A., Marchesi E., Bianchi B., and Canonica G.W. Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis. Annals of Allergy, Asthma and Immunology 75 2 (1995) 115-120
14. Thomas M., Sheran J., Smith N., Fonseca S., and Lee A.J. AKL1, a botanical mixture for the treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over study. BMC Pulmonary Medicine 7 (2007) 4
15. Evald T., Munch E.P., and Kok-Jensen A. Chronic non-asthmatic cough is not affected by inhaled beclomethasone dipropionate. A controlled double blind clinical trial. Allergy 44 7 (1989) 510-514
16. Malo J.L., Cartier A., Cote J., Milot J., Leblanc C., Paquette L., et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. American Journal of Respiratory and Critical Care Medicine 153 3 (1996) 953-960
17. Freeman L.W., and Welton D. Effects of imagery, critical thinking, and asthma education on symptoms and mood state in adult asthma patients: a pilot study. Journal of the Alternative and Complementary Medicine 11 1 (2005) 57-68
18. Ribeiro M., Pereira C.A., Nery L.E., Beppu O.S., and Silva C.O. High-dose inhaled beclomethasone treatment in patients with chronic cough: a randomized placebo-controlled study. Annals of Allergy, Asthma and Immunology 99 1 (2007) 61-68
19. Rouhi H., Ganji F., and Nasri H. Effects of ginger on the improvement of asthma (The evaluation of its' treatmental effects). Pakistan Journal of Nutrition 5 4 (2006) 373-376
20. -1) in patients with asthma. Respiratory Medicine 95 3 (2001) 212-220
21. Ayres J.G., Simmons J.L., and Stampone P. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients. Respiratory Medicine 93 1 (1999 Jan) 27-32
22. Dahl R., Ringdal N., Ward S.M., Stampone P., and Donnell D. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate. British Journal of Clinical Practice 51 1 (1997 Jan-Feb) 11-15
23. Dorow P., and Schiess W. The influence of ketotifen and aminophylline on the central and peripheral airways. Arzneimittelforschung 33 2 (1983) 265-268
24. Monie R.D., Smith A.P., Leopold D., Anderson G., Davies B.H., and Thomas G.O. A double-blind clinical-trial of ketotifen and disodium-cromoglycate in bronchial-asthma. British Journal of Diseases of the Chest 76 4 (1982) 383-389
25. Spector S.L., and Tan R.A. Effectiveness of montelukast in the treatment of cough variant asthma. Annals of Allergy, Asthma and Immunology 93 3 (2004) 232-236
26. Callaghan B., Teo N.C., and Clancy L. Effects of the addition of nedocromil sodium to maintenance bronchodilator therapy in the management of chronic asthma. Chest 101 3 (1992) 787-792
27. Creticos P., Burk J., Smith L., Comp R., Norman P., and Findlay S. The use of twice daily nedocromil sodium in the treatment of asthma. Journal of Allergy and Clinical Immunology 95 4 (1995) 829-836
28. Fink J.N., Forman S., Silvers W.S., Soifer M.M., Tashkin D.P., and Wilson A.F. A double-blind study of the efficacy of nedocromil sodium in the management of asthma in patients using high doses of bronchodilators. Journal of Allergy and Clinical Immunology 94 3 Pt 1 (1994) 473-481
29. Wasserman S.I., Furukawa C.T., Henochowicz S.I., Marcoux J.P., Prenner B.M., Findlay S.R., et al. Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol. Journal of Allergy and Clinical Immunology 95 2 (1995) 541-547
30. Connolly K.C., Peake M.D., Halpin D.M.G., Golightly L., and Turbitt M.L. Challenging current asthma treatment guidelines: improved control of asthma symptoms with nebulised budesonide in patients with severe asthma receiving continuous oral steroids. Disease Management and Health Outcomes 7 4 (2000) 217-225
31. Ostojic V., Cvoriscec B., Ostojic S.B., Reznikoff D., Stipic-Markovic A., and Tudjman Z. Improving asthma control through telemedicine: a study of short-message service. Telemedicine Journal and e-Health 11 1 (2005 Feb) 28-35
32. Shioya T., Satake M., Sano M., Kagaya M., Watanabe A., Sato K., et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma. European Journal of Clinical Pharmacology 58 3 (2002) 171-176
33. Govindan S., Viswanathan S., Vijayasekaran V., and Alagappan R. Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. Phytotherapy Research 18 10 (2004) 805-809
34. Eriksson N.E., Haglind K., and Ewald U. Combined theophylline/beta-agonists maintenance therapy in chronic asthma. European Journal of Respiratory Diseases 64 3 (1983 Apr) 172-177
35. Dicpinigaitis P.V., Dobkin J.B., and Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. Journal of Asthma 39 4 (2002) 291-297
36. Simon S.W. Symptomatic treatment of asthmatic bronchitis. Journal of the American Geriatric Society 8 (1960) 107-111
37. Martinez-Garcia M.A., Perpina-Tordera M., Roman-Sanchez P., and Soler-Cataluna J.J. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respiratory Medicine 100 9 (2006) 1623-1632
38. Dueholm M., Nielsen C., Thorshauge H., Evald T., Hansen N.C., Madsen H.D., et al. N-acetylcysteine by metered dose inhaler in the treatment of chronic bronchitis: a multi-centre study. Respiratory Medicine 86 2 (1992) 89-92
39. Jackson I.M., Barnes J., and Cooksey P. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study. Journal of International Medical Research 12 3 (1984) 198-206
40. Engel T., Heinig J.H., Madsen O., Hansen M., and Weeke E.R. A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. European Respiratory Journal 2 10 (1989) 935-939
41. Shioya T., Satake M., Kagaya M., Sano M.A., Watanabe A., Fukui S., et al. Antitussive effects of the H1-receptor antagonist epinastine in patients with atopic cough (eosinophilic bronchitis). Arzneimittel-Forschung 54 4 (2004) 207-212
42. Volkova L.I., Budkova A.A., Filonova N.N., Khristolyubova E.I., Kutuzova E.B., Koroleva N.V., et al. Efficacy of supplemental anti-inflammatory therapy with fenspiride in chronic obstructive and nonobstructive bronchitis. Clinical Drug Investigation 25 4 (2005) 257-264
43. Repsher L.H. Treatment of stable chronic bronchitis with iodinated glycerol: a double-blind, placebo-controlled trial. Journal of Clinical Pharmacology 33 9 (1993) 856-860
44. Petty T.L. The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. [see comment]. Chest 97 1 (1990) 75-83
45. Passeri M., Ippolito L., Valenti G., Denti L., Bernocchi D., and Ceresini G. A new twice-daily slow-release theophylline suspension (Teonova Syrup). Clinical experience in broncho-obstructive chronic pathology of the eldery. Clinical Trials Journal 25 2 (1988) 93-102
46. Nicolis F.B., and Pasquari G. Controlled clinical trials of antitussive agents - experimental evaluation of different methods. Journal of Pharmacology and Experimental Therapeutics 136 2 (1962) 183-189
47. Auffarth B., Postma D.S., de Monchy J.G., van der Mark T.W., Boorsma M., and Koeter G.H. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax 46 5 (1991) 372-377
48. Smith J., Owen E., Earis J., and Woodcock A. Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology 117 4 (2006) 831-835
49. Giovannini M., Perri G., Rocca A., and Spada E. Efficacy and tolerability of domiodol (Mucolitico Maggioni) in long-term treatment of patients with chronic bronchitis. Clinical Trials Journal 25 3 (1988) 211-218
50. Shmelev E.I., and Kunicina Y.L. Comparison of fenspiride with beclomethasone as adjunctive anti-inflammatory treatment in patients with chronic obstructive pulmonary disease. Clinical Drug Investigation 26 3 (2006) 151-159
51. Paggiaro P.L., Dahle R., Bakran I., Frith L., Hollingworth K., and Efthimiou J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. [see comment][erratum appears in Lancet 1998 Jun 27;351(9120):1968]. Lancet 351 9105 (1998) 773-780
52. Campbell M., Eliraz A., Johansson G., Tornling G., Nihlen U., Bengtsson T., et al. Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Respiratory Medicine 99 12 (2005) 1511-1520
53. Sergysels R.A.G. A double-masked, placebo-controlled polysomnographic study of the antitussive effects of helicidine. Current Therapeutic Research 62 1 (2001) 35-47
54. Friedman M.A. Multicenter study of nebulised bronchodilator solutions in chronic obstructive pulmonary disease. The American Journal of Medicine 100 (1996) 1A-39S
55. Chong C.F., Chen C.C., Ma H.P., Wu Y.C., Chen Y.C., and Wang T.L. Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease. Emergency Medicine Journal 22 6 (2005) 429-432
56. Zuin R., Palamidese A., Negrin R., Catozzo L., Scarda A., and Balbinot M. High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease. Clinical Drug Investigation 25 6 (2005) 401-408
57. Paggiaro P.L., Vagaggini B., Di Franco A., Zingoni M., Fano M., and Biraghi M. Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease. Respiration 73 5 (2006) 603-609
58. Cattaneo C. Neltenexine tablets in smoking and non-smoking patients with COPD. A double-blind, randomised, controlled study versus placebo. Minerva Medica 92 4 (2001) 277-284
59. D'Elia C.S.F. Neltenexine versus carbocysteine in the treatment of exacerbations of mild chronic obstructive pulmonary disease: a randomized, controlled, open-label study. Current Therapeutic Research 62 12 (2001) 851-861
60. Fadda G. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol. Minerva Medica 92 4 (2001 Aug) 269-275
61. Todisco T., Trippetti M., Vernelli C., Cardillo G., Jannacci L., and Spigarelli E. Effect of nesosteine, a new muco-active agent on mucociliary clearance in bronchitic patients. Clinical Trials Journal 25 5 (1988) 315-322
62. Bellia V., Foresi A., Bianco S., Grassi V., Olivieri D., Bensi G., et al. Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH trial). Respiratory Medicine 96 11 (2002) 881-889
63. Kanner R.E., Connett J.E., Williams D.E., and Buist A.S. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the lung health study. American Journal of Medicine 106 4 (1999) 410-416
64. Thomas P., St. Pierre M., and Hidinger K.-G. Theophylline blood level and pulmonary function tests utilizing standard and sustained-release theophylline tablets. Current Therapeutic Research 35 3 (1984) 331-336
65. Pizzichini M.M.M., Pizzichini E., Parameswaran K., Clelland L., Efthimiadis A., Dolovich J., et al. Nonasthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Canadian Respiratory Journal 6 4 (1999) 323-330
66. Morice A.H., Menon M.S., Mulrennan S.A., Everett C.F., Wright C., Jackson J., et al. Opiate therapy in chronic cough. American Journal of Respiratory and Critical Care Medicine 175 4 (2007) 312-315
67. Vertigan A.E., Theodoros D.G., Gibson P.G., and Winkworth A.L. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax 61 12 (2006 Dec) 1065-1069
68. Sevelius H., and Colmore J.P. Objective assessment of antitussive agents in patients with chronic cough. The Journal of New Drugs 6 4 (1966 Jul-Aug) 216-223
69. Vaezi M.F., Richter J.E., Stasney C.R., Spiegel J.R., Iannuzzi R.A., Crawley J.A., et al. Treatment of chronic posterior laryngitis with esomeprazole. The Laryngoscope 116 2 (2006 Feb) 254-260
70. Baldi F., Cappiello R., Cavoli C., Ghersi S., Torresan F., and Roda E. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World Journal of Gastroenterology 12 1 (2006) 82-88
71. Kiljander T.O., Salomaa E.R.M., Hietanen E.K., and Terho E.O. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. European Respiratory Journal 16 4 (2000) 633-638
72. Noordzij J.P., Khidr A., Evans B.A., Desper E., Mittal R.K., Reibel J.F., et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. The Laryngoscope 111 (2001) 2147-2151
73. Ours T.M., Kavuru M.S., Schilz R.J., and Richter J.E. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. American Journal of Gastroenterology 94 11 (1999 Nov) 3131-3138
74. Crimi E., Orefice U., De Benedetto F., Grassi V., and Brusasco V. Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease. Annals of Allergy, Asthma and Immunology 74 6 (1995) 501-508
75. Bisetti A., and Mancini C. Mucolytic activity of erdosteine double blind clinical trial vs placebo. Archivio di Medicina Internazionale 47 4 (1995) 89-97
76. Lillenfield L.S., Rose J.C., and Princiotto J.V. Antitussive activity of diphenhydramine in chronic cough. Clinical Pharmacology and Therapeutics 19 4 (1976) 421-425
77. Li J., Zheng J.P., Yuan J.P., Zeng G.Q., Zhong N.S., and Lin C.Y. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. Chinese Medical Journal 117 6 (2004) 828-834
78. Del Donno M., Aversa C., Corsico R., Forsesi A., Grassi V., Malerba M., et al. Efficacy and safety of moguisteine in comparison with dextromethorphan in patients with persistent cough. Drug Investigation 7 2 (1994) 93-100
79. Aquilina R., Bergero F., Noceti P., and De Michelis C. Double blind study with neltenexine vs placebo in patients affected by acute and chronic lung diseases. Minerva Pneumologica 40 2 (2001) 77-82
80. Caporalini R., and Giosue G.L. Neltenexine in lung diseases: an open, randomised, controlled study versus N-acetylcysteine comparison. Minerva Pneumologica 40 2 (2001) 57-62
81. Chernish S.M., Kraft B., Lewis G., and Howell J. Clinical evaluation of a new antitussive preparation. Annals of Allergy 21 12 (1963) 677
82. Beulcke G. Acebrophylline and theophylline in the treatment of bronchial asthma. An open comparative, randomized study. Acta Therapeutica 21 2 (1995) 101-111
83. Tatsis G., Kotsifas K., Filaditaki V., Makrantoni G., and Boulia S. Efficacy of beclomethasone dipropionate HFA 200 μg once daily in chronic obstructive pulmonary disease and bronchial asthma. Journal of International Medical Research 35 3 (2007) 361-373
84. Verver S., Poelman M., Bogels A., Chisholm S.L., and Dekker F.W. Effects of instruction by practice assistants on inhaler technique and respiratory symptoms of patients. A controlled randomized videotaped intervention study. Family Practice 13 1 (1996) 35-40
85. Chaudhuri R., McMahon A.D., Thomson L.J., MacLeod K.J., McSharry C.P., Livingston E., et al. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. Journal of Allergy and Clinical Immunology 113 6 (2004) 1063-1070
86. Berthelot J., and Weibel M.A. Comparative clinical evaluation of the antitussive activity of butamirate citrate linctus (Sinecod) v. a codeine-containing linctus (Netux). Clinical Trials Journal 27 1 (1990) 50-57
87. Mann J.S., Clement P., Sheridan A.Q., Soryal I., Fairfax A.J., and Holgate S.T. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study. Journal of Allergy and Clinical Immunology 76 1 (1985) 83-90
88. Chang A.B., Lasserson T.J., Gaffney J., Connor F.L., and Garske L.A. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database of Systematic Reviews 18 4 (2006) CD004823
89. Jan R.L., Wang J.Y., Huang M.C., Tseng S.M., Su H.J., and Liu L.F. An internet-based interactive telemonitoring system for improving childhood asthma outcomes in Taiwan. Telemedicine Journal and e-Health 13 3 (2007 Jun) 257-268
90. Kearney N., McCann L., Norrie J., Taylor L., Gray P., McGee-Lennon M., et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care in Cancer 17 4 (2009 Apr) 437-444
91. Chung K.F. Chronic cough: future directions in chronic cough: mechanisms and antitussives. Chronic Respiratory Disease 4 3 (2007) 159-165
92. Irwin R.S. Assessing cough severity and efficacy of therapy in clinical research: aCCP evidence-based clinical practice guidelines. Chest 129 Suppl. 1 (2006 Jan) 232S-237S
93. Pavord I.D., and Chung K.F. Management of chronic cough. Lancet 371 9621 (2008 Apr 19) 1375-1384
94. Palombini B.C., Villanova C.A., Araujo E., Gastal O.L., Alt D.C., Stolz D.P., et al. A pathogenic triad in chronic cough: asthma, postnasal drip syndrome, and gastroesophageal reflux disease. Chest 116 2 (1999 Aug) 279-284